Contact Person : Alison Carley; Last Date for the submission of abstract : 19/09/2016; Description : Explore approaches for complex drug development and regulation, outstanding challenges in the assessment of complex drug equivalence, consequences for product interchangeability, and compare biological and non-biological complex drug families.